Michael Narachi, Director at AMAG PHARMACEUTICALS INC. (AMAG), bought 2,000 shares at $13.55 ($27K) on 2012-05-24, disclosed to the SEC on 2012-05-29.
Open-market purchase of $27k AMAG by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| OREX | SELL | 2012-07-19 | $1.1M | — | Filing → |
| OREX | SELL | 2012-07-13 | $1.0M | — | Filing → |
| OREX | SELL | 2012-06-29 | $1.3M | — | Filing → |